Monopoly Rights for Levosulpiride 75mg

Maximize Profit: Target High-Volume GERD/IBS Market

Single-Dose Tablet = Guaranteed Refills

Secure Your Exclusive GI Territory Today

Full Marketing & Field Support Provided
Launch Your Top-Margin Tablet Business Now!

Home/Products /levosulpiride-75-mg-tablet

Lesutype 75 Tablet

Composition : Dicyclomine 20mg + Paracetamol 325mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Lesutype 75mg (Levosulpiride 75mg) is your proven path to high profit in the massive Gastrointestinal market.

This tablet is the essential treatment for stomach issues like GERD and IBS. The key advantage is the single, powerful 75mg dose. Doctors prescribe this because it works fast and patients only need one tablet a day, which means you get reliable, steady refills every month.

Why Levosulpiride 75mg is Your Best Franchise:

  • Chronic Business: Stomach/IBS issues never go away, ensuring consistent monthly sales.

  • High Margins: This is a top-tier GI drug, meaning better profit per strip.

  • Easy to Sell: Doctors know the molecule; you just need to offer the best monopoly deal.

Secure your exclusive Levosulpiride 75mg territory now!

Read More

About the Product

Lesutype 75mg (Levosulpiride 75mg) is your proven path to high profit in the massive Gastrointestinal market.

This tablet is the essential treatment for stomach issues like GERD and IBS. The key advantage is the single, powerful 75mg dose. Doctors prescribe this because it works fast and patients only need one tablet a day, which means you get reliable, steady refills every month.

Why Levosulpiride 75mg is Your Best Franchise:

  • Chronic Business: Stomach/IBS issues never go away, ensuring consistent monthly sales.

  • High Margins: This is a top-tier GI drug, meaning better profit per strip.

  • Easy to Sell: Doctors know the molecule; you just need to offer the best monopoly deal.

Secure your exclusive Levosulpiride 75mg territory now!

Some common side effects of Scotspas P may include dizziness, nausea, dry mouth, or drowsiness. In rare cases, it may cause allergic reactions or difficulty in urination. If any side effects persist or worsen, contact your healthcare provider.

Scotspas P is indicated for the relief of abdominal pain and discomfort, particularly associated with gastrointestinal issues like irritable bowel syndrome (IBS), bloating, and cramps. It is effective in treating spasms and providing pain relief.

Do not use Scotspas P if you are allergic to any of its components. Pregnant or breastfeeding women should consult a doctor before use. It is important to follow the prescribed dosage and not to exceed the recommended dose.

Store at room temperature, away from sunlight and moisture, and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation